Publications of U. Reichl
All genres
Poster (338)
2003
Poster
Serum-free cultivation of CEF for vaccine production in microcarrier-systems. 18th ESACT Meeting, Granada, Spain (2003)
Poster
Mathematical Modeling of MDCK Cell Growth by the Use of On-line Data. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)
Poster
Investigation of a new, sterile, deadvolume free sampling-system for universal applications, automated and suitable for online-analyzing. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)
Poster
Cooperation and competition: studies on heterogeneous microbial cultures. Jahrestagung der Vereinigung für allgemeine und angewandte Mikrobiologie (VAAM), Berlin, Germany (2003)
Poster
Structured model of Influenza virus replication in MDCK cells. 11th Congress on biotechnology, Basel, Switzerland (2003)
2002
Poster
Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. IUMS 2002, Paris, France (2002)
Poster
Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. GVC/Dechema Jahrestagungen 2002, Wiesbaden, Germany (2002)
2001
Poster
Development of bioprocess concepts on vaccine production: influenza virus as an example. 17th ESACT Meeting, Tyloesand, Sweden (2001)
Issue (1)
2015
Issue
10, (5) (2015)
Vaccine Biotechnology (Special issue). Biotechnology Journal Editorial (2)
2021
Editorial
Preface to Advances in Glycobiotechnology. Advances in Glycobiotechnology, pp. i - vi (2021)
2015
Editorial
10 (5), pp. 657 - 658 (2015)
Can modern vaccine technology pursue the success of traditional vaccine manufacturing? Biotechnology Journal Patent (3)
2020
Patent
Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use. US 2020/0392504A1 (2020)
2019
Patent
Plug Flow Tubular Bioreactor , System Containing the same and Method for Production of Virus. US 20190119616A1 (2019)
Patent
Method for the Separation of Virus Compositions Including Depletion and Purification thereof. US 20190085300A1 (2019)
Preprint (5)
2024
Preprint
Detection, isolation and characterisation of phage-host complexes using BONCAT and click chemistry. (2024)
Preprint
Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. (2024)
2021
Preprint
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. (2021)
Preprint
Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particles. (2021)
Preprint
Critical Assessment of Metaproteome Investigation (CAMPI): A Multi-Lab Comparison of Established Workflows. (2021)